Navigation Links
Biopharma M&A Trends Hold Steady, But Deals Declined in 2011

ATLANTA, April 25, 2012 /PRNewswire-USNewswire/ -- Given the narrow initial public offering window, declining venture investments and tough capital markets, mergers and acquisitions (M&A) have become the exit of choice for many biopharmaceutical companies. In 2011, there were more M&As than in 2010, deal value was higher, but it still wasn't the flood of deals many industry observers had expected, according to BioWorld.

Another not-so-positive trend for biotech in 2011 was the continued decline in the number of collaborations. A total of 465 licensing or partnership transactions closed last year, compared to 592 in 2010. In 2009, a total of 650 deals got done, as reported in the just-published BioWorld Biotechnology State of the Industry Report 2012.

In the wake of the 2008 recession, many biotech players were left with insufficient cash and depressed values, while cash-rich pharmas have been facing the dreaded patent cliff, creating an environment that appeared ripe for a massive wave of consolidation. Analysts predicted a frenzy of M&As, but BioWorld reports that those predictions have not been borne out.

"The big pharma mega mergers of 2009 tamped down biotech acquisitions that year, and the 'digestion' of those mergers was attributed to the slower-than-expected M&A trends in 2010," said Jennifer Boggs, BioWorld's managing editor. "Hopes were high going into 2011, but the once-again anticipated rush of M&A activity still did not emerge. Acquisition trends in the life sciences space held steady at best."

"2012 may be a different story," said Lynn Yoffee, BioWorld's executive editor. "With four biopharma billion-dollar-plus M&A deals already, the average deal size will undoubtedly increase."

M&A and deals activity are just one section of BioWorld's annual report.

"The BioWorld news team also analyzed financing, scientific and regulatory trends for 2011, putting the information and data in context with what's happening now and going forward in 2012," Yoffee said. "It's a vital resource on key trends designed to guide executives' decision-making as they prep for the next big deal or when strategizing about fundraising. Near-term biopharma sector history is the best guide for smart planning."

BioWorld is the biopharmaceutical industry's most respected news source for more than two decades. For a copy of the BioWorld Biotechnology State of the Industry Report 2012, call (800) 477-6307 or, outside the U.S., (404) 262-5476 or visit

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Equity Research on Most Popular Searches: Atmel, USG, Applied Materials, Sprint Nextel, Galena Biopharma, and Key Energy Services
2. PAREXEL Global Survey Results Identify Top Concerns of Biopharma Industry in Achieving Commercial Success
3. Pharmspective Announces the Release of ClearView™ - a New Health Care Reform Knowledge Management Web Application for the Biopharma Industry
4. PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes
5. Medtrack One View - A New More Powerful Biopharmaceutical Intelligence Tool Is Now Available
6. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results
7. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year-End 2011 Financial Results
8. Innovative School of BioPharmacy to Open in Fall 2014
9. The Centers for Disease Control & Prevention Signs Vaccine Warehouse and Distribution Contract with Sentry BioPharma Services
10. PDL BioPharma to Announce Fourth Quarter and Full Year 2011 Financial Results on February 23, 2012
11. Top 200 Biopharmaceuticals Industry Report (Global)
Post Your Comments:
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
Breaking Medicine News(10 mins):